Dr Andrew Holmes graduated with a first class honours degree in BMedSc (specialising in Physiology) from the University of Birmingham, in 2009. He was awarded the Arthur Thompson prize for achieving the highest position in his degree class.
Dr Holmes completed a PhD at the University of Birmingham, working with Professor Prem Kumar, where he became interested in understanding how arterial chemoreceptors sense and respond to changes in blood O2, CO2, pH and glucose. During his PhD he was awarded the A.E. Hills Postgraduate Scholarship.
Dr Holmes did a 4-year Postdoctoral research post in the Translational Research on Heart Failure and Arrhythmia Research Cluster in the Institute of Cardiovascular Science, working with advisors Professor Paulus Kirchhof and Dr Larissa Fabritz. During this time he was awarded the British Society for Cardiovascular Research and British Atherosclerosis Society Young Investigator Award.
In 2018, Dr Holmes took up a Lecturer position in the Institute of Clinical Sciences, University of Birmingham. He is currently joint group lead of the Birmingham Arterial Chemoreceptor and Hypoxia Group. He also continues to be an active member of the Translational Research on Heart Failure and Arrhythmias Cluster in the Institute of Cardiovascular Science.
Dr Holmes has published a number of research articles in internationally recognised journals including
- Journal of American College Cardiology
- Circulation Research
- Journal of Physiology
- American Journal of Respiratory and Critical Care Medicine
He has received funding from the BHF, MRC and Wellcome Trust.